Malaria vaccine found safe in early clinical trial: Study

A new study published in the journal Clinical Infectious Diseases has revealed that a new vaccine developed by scientists to provide protection against pregnancy-associated malaria was found safe in an early clinical trial.

By: Agencies | | Published: January 12, 2019 10:48 am

Malaria in pregnancy has major impacts on mother and child health. © Shutterstock

A vaccine developed with the aim of protecting against pregnancy-associated malaria was found safe in an early clinical trial. Also Read - World Malaria Day 2020: Importance, theme and history

Also Read - Fight malaria with our natural remedies

Malaria in pregnancy has major impacts on mother and child health. The current strategy to prevent pregnancy-associated malaria (PAM) comprises intermittent preventive treatment and use of insecticidal nets. Also Read - Want to tame the malaria parasite? These are the right moves

The new vaccine, developed by a team of researchers at the University of Copenhagen in Denmark, passed the test by inducing the right antibody response in the blood, according to a study published in the journal Clinical Infectious Diseases.

“It is a great milestone for us to be able to show that our vaccine is completely safe and induces the exact antibody response in the blood we want because it is the immune response that has been shown to be connected with protection from pregnancy malaria,” said Morten Agertoug Nielsen, Associate Professor at University of Copenhagen.

For the study, the researchers examined the effect of the vaccine among 36 people in Germany.

After injecting the participants with the vaccine, the researchers were able to detect the right immune response with antibodies against the malaria parasite in the blood, and the participants showed no serious side effects.

“The next step in the process is a phase two clinical trial, which will show whether the vaccine is still safe, but also whether it can prevent disease,” said Nielsen.

“Concurrently, we have developed a method for transforming the vaccine into a virus-like particle. This increases the antibody response. But the crux of the matter is whether it is sufficient for attacking all the different forms of the protein hook found in the malaria parasite,” Nielsen noted.

Source: IANS

Published : January 12, 2019 10:48 am

Read Disclaimer

Scientists develop new device to reduce chemotherapy's harmful side effects: Study

An inexpensive DIY technology helping villagers in Assam to counter contaminated water

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

Scientists develop new device to reduce chemotherapy's harmful side effects: Study

An inexpensive DIY technology helping villagers in Assam to counter contaminated water

World Malaria Day 2020: Importance, theme and history

Fight malaria with our natural remedies

Want to tame the malaria parasite? These are the right moves

WHO says India one of the only two countries to reduce malaria burden in 2018: Know how to prevent this disease

Malaria can thrive in cooler climes too: Know the risks and protect yourself

About The health Site

Useful Links